CAMBRIDGE, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced that Dr. Abbie Celniker, senior vice president of R&D strategy and operations and pharmaceutical sciences, has been honored by the Massachusetts Technology Leadership Council for her contribution of winning ideas and best practices to the technology industry and Massachusetts business community.
(Logo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
"Dr. Celniker and the other Mass Technology Leadership Council Award honorees have established themselves as forces for change in the way business is conducted," said Mass Technology Leadership Council vice president Tom Hopcroft.
"I am truly honored by this award, as it recognizes Millennium as not only a leader in the biopharmaceutical industry, but also a pioneer in bringing innovation to the broader Massachusetts high-tech community," said Dr. Celniker.
Dr. Celniker is responsible for multiple aspects of product development at Millennium, including chemistry manufacturing and control development activities, the oversight of the pipeline portfolio, project management activities, as well as integrating R&D strategy with corporate strategy. She is an active participant in several regional industry organizations, and serves on the Board of Directors of the Massachusetts Biotechnology Council.
About the Mass Technology Leadership Council Awards
The 2005 Awards program began in the first quarter with an open nomination process. Thirty finalists were announced in May and final selections were based on nominee achievements, experiences and insights that were provided by the nominees through subsequent panels and interactions. Selections were made by a voting process among the Council's selection committee and key advisors.
The Association will begin accepting nominations for the 2006 Mass Technology Leadership Council Awards in January 2006. Finalists will be named in June and winners announced in October 2006. For more information, visit http://www.masstechleaders.org.
The Mass Technology Leadership Council is the premier association for providers and users of innovative technologies in the region. Formed by the combination of Mass Software Council and New England Business and Technology Association, Inc., the organization is dedicated to fostering entrepreneurship and promoting the success of companies that develop and deploy technology across industry sectors. The Mass Technology Leadership Council conducts educational programs, hosts industry events, facilitates networking, sponsors research, advocates on behalf of its members, and is involved in a variety of activities that will help to produce the next generation of STEM (Science Technology Engineering and Mathematics) professionals.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, its understanding of disease mechanisms and its industrialized drug discovery platform, Millennium is seeking to develop breakthrough products. The Company's website is http://www.millennium.com.
Editor's Note: This release is available on the Media section of the Millennium website at http://www.millennium.com
Contacts:
Theresa McNeely (media) Kyle Kuvalanka (investors) (617) 679-7405 (617) 761-4734
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.CONTACT: Theresa McNeely (media), +1-617-679-7405, or Kyle Kuvalanka(investors), +1-617-761-4734, both of Millennium
Web site: http://www.millennium.com//
Company News On-Call: http://www.prnewswire.com/comp/114562.html/
